Bormioli Rocco Pharma offers new packaging solutions for powdered oral drugs, parenteral drugs, pediatric syrups, and protein-based drugs.
Bormioli Rocco Pharma, a glass and plastic manufacturer, is addressing crucial pharmaceutical market needs by developing innovative packaging solutions. These include:
“Detecting unmet market need is the first step for the development of packaging solutions at Bormioli Rocco Pharma,” said Elena Piazza, business development and marketing manager, in an Oct. 24, 2017 press release. “From there, in active synergy with our pharmaceutical partners, we work intensively on specific project requirements, collaborating at every phase, to effectively integrate packaging and drug product to achieve our most important objective-improving people’s lives worldwide.”
AccuRec, a dual-chamber package, enables end-users to reconstitute oral drugs in a few steps. It provides predosed diluent and drug powder, ensuring the effective mix of both just before its administration to a patient. Powdered oral drugs are expected to have wider diffusion as unstable drug formulation volumes continuously increase. Reconstitution is a complex procedure, involving both pharmacist and patient. The redesigned package improves reconstitution.
Delta Type I glass vials are specifically designed to address damage or breakage to glass during the lyophilization process. Many new parenterals, including anti-infectives, biotechnology derived products, and in vitro diagnostics, are manufactured as lyophilized products. Manufacturing technology used for the new vials ensures mechanical and chemical resistance, as well as product dimensional stability and controlled thermal parameters. As a result, freeze-drying process operations are made leaner and more efficient, without damage to the glass vial.
Safe&Easy is a packaging kit for pediatric oral drugs designed to avoid plug ingestion and to provide a precise syrup dose. One of the most urgent topics in pediatric dosing is the risk of injuries caused by unsafe oral drug packaging, in which unsecured plugs can be ingested by the patient, says the company.
To make therapies widely available in emerging countries, inhalable vaccines and drugs are expected to become a good alternative to injectable products. Nesat is a dry powder inhaler developed to support inhalable drug diffusion using a simple, safe, and user-friendly design. The use of plastic components gives the device flexibility to adapt to specific formulation needs, offering a versatile packaging solution to pharmaceutical companies serving emerging nations.
The global protein-based drug market is growing, and the high sensitivity of protein-based drugs results in an increasing demand for packaging with enhanced drug protection features. Bormioli Rocco Pharma’s Amber Type I glass vials offer protection from both chemical and environmental aggressions for protein-based drugs.
Source: Bormioli Rocco Pharma